VEGFA and arthritic joint disease: This concept is further supported by findings from a proteoglycan-induced arthritis model, where intra-articular administration of the VEGF decoy receptor sFlt-1 led to reduced arthritis severity and macrophage infiltration, likely via VEGFR2-mediated suppression of vascular permeability and monocyte recruitment [44].